UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials

The Journal of dermatological treatment, 2022-05, Vol.33 (4), p.2241-2249

2022

Volltextzugriff (PDF)

Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications

Journal of drugs in dermatology, 2020-03, Vol.19 (3), p.30

2020

Volltextzugriff (PDF)

Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2220446-2220446

2023

Volltextzugriff (PDF)

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2147391-2147391

2023

Volltextzugriff (PDF)

Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist

Expert opinion on pharmacotherapy, 2021-09, Vol.22 (13), p.1801-1806

Kircik, Leon H.

2021

Volltextzugriff (PDF)

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients

The Journal of dermatological treatment, 2022-08, Vol.33 (6), p.2790-2799

2022

Volltextzugriff (PDF)

Game Changer in Acne Treatment

Journal of drugs in dermatology, 2020-03, Vol.19 (3), p.28

Kircik, Leon H

2020

Volltextzugriff (PDF)

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis

Dermatology and therapy, 2024-05, Vol.14 (5), p.1211-1227

2024

Volltextzugriff (PDF)

Importance of Vehicles in Topical Treatment of Fungal Infections

Clinics in podiatric medicine and surgery, 2016-07, Vol.33 (3), p.385-395

Kircik, Leon H., MD

2016

Volltextzugriff (PDF)

The New Psoriasis Paradigm: Striving for Complete Clearance

Journal of drugs in dermatology, 2020-06, Vol.19 (6), p.652

Kircik, Leon H

2020

Volltextzugriff (PDF)

Addressing the Challenges of Treating Actinic Keratosis

Journal of drugs in dermatology, 2019-05, Vol.18 (5), p.s160

Kircik, Leon H.

2019

Volltextzugriff (PDF)

INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update

Journal of drugs in dermatology, 2024-02, Vol.23 (2), p.SF37896s4

2024

Volltextzugriff (PDF)

Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study

Journal of drugs in dermatology, 2011-06, Vol.10 (6), p.586

Kircik, Leon H

2011

Volltextzugriff (PDF)

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

The New England journal of medicine, 2020-07, Vol.383 (3), p.229-239

2020

Volltextzugriff (PDF)

A Novel Technology: Sunscreen With Actinic Damage Repair

Journal of drugs in dermatology, 2017-05, Vol.16 (5), p.s59

Kircik Md, Leon H

2017

Volltextzugriff (PDF)

Depression? It's the Disease NOT the Drug

Journal of drugs in dermatology, 2018-08, Vol.17 (8), p.s28

Kircik, Leon H

2018

Volltextzugriff (PDF)

Yes to Appropriate Compounding, No to Illegal Compounding

Journal of drugs in dermatology, 2018-07, Vol.17 (7), p.s15

Kircik, Leon H

2018

Volltextzugriff (PDF)

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (11), p.1073

2022

Volltextzugriff (PDF)

Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris

Journal of drugs in dermatology, 2017-06, Vol.16 (6), p.543

Kircik, Leon H

2017

Volltextzugriff (PDF)

Actinic Keratosis: Current Therapies and Insights Into New Treatments

Journal of drugs in dermatology, 2019-05, Vol.18 (5), p.s161

2019

Volltextzugriff (PDF)

Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment

Journal of drugs in dermatology, 2016-02, Vol.15 (2), p.191

Kircik, Leon H

2016

Volltextzugriff (PDF)

Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications

Journal of drugs in dermatology, 2010-11, Vol.9 (11), p.1407

Kircik, Leon H

2010

Volltextzugriff (PDF)

Advances in the Understanding of the Pathogenesis of Inflammatory Acne

Journal of drugs in dermatology, 2016-01, Vol.15 (1 Suppl 1), p.s7

Kircik, Leon H

2016

Volltextzugriff (PDF)

Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important

Journal of drugs in dermatology, 2017-08, Vol.16 (8), p.s113

Kircik, Leon H

2017

Volltextzugriff (PDF)

New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach

Journal of drugs in dermatology, 2017-11, Vol.16 (11), p.s135

2017

Volltextzugriff (PDF)

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(189)

Erscheinungsjahr

n.n

Thema

Humans
(138)
Dermatology
(117)
Life Sciences & Biomedicine
(117)
Science & Technology
(117)
Female
(58)
Treatment Outcome
(57)
Adult
(54)
Male
(51)
Middle Aged
(43)
Administration, Cutaneous
(39)
Acne Vulgaris - Drug Therapy
(38)
Dermatologic Agents - Administration & Dosage
(34)
Young Adult
(33)
Dermatologic Agents - Therapeutic Use
(31)
Psoriasis - Drug Therapy
(31)
Severity Of Illness Index
(30)
Administration, Topical
(29)
Adolescent
(27)
Double-Blind Method
(26)
Aged
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dermal sensitization, safety, tolerability, and patient preference of tazarotene 0.045% lotion from five clinical trials

Androgens, Androgen Receptors, and the Skin: From the Laboratory to the Clinic With Emphasis on Clinical and Therapeutic Implications

Dermal sensitization, safety, and tolerability of triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel from three clinical trials

Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin

Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist

Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients

Game Changer in Acne Treatment

Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis

Importance of Vehicles in Topical Treatment of Fungal Infections

The New Psoriasis Paradigm: Striving for Complete Clearance

Addressing the Challenges of Treating Actinic Keratosis

INDIVIDUAL ARTICLE: Antibiotic Stewardship in Acne: 2023 Update

Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study

Trial of Roflumilast Cream for Chronic Plaque Psoriasis

A Novel Technology: Sunscreen With Actinic Damage Repair

Depression? It's the Disease NOT the Drug

Yes to Appropriate Compounding, No to Illegal Compounding

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials

Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris

Actinic Keratosis: Current Therapies and Insights Into New Treatments

Use of Dapsone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Dapsone 5% Gel Combination Treatment

Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications

Advances in the Understanding of the Pathogenesis of Inflammatory Acne

Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important

New Insight Into the Pathophysiology of Hair Loss Trigger a Paradigm Shift in the Treatment Approach

Suchergebnisse filtern